Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis-Reference-Cited by-同舟云学术

Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis

Published:2022-03-11 Issue:14 Volume:11 Page:2846-2854
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Huang Yun‐xia¹^ORCID,Lin Yan‐zong²,Li Yi‐min¹,Chu Ke‐xin¹,Zhou Yu‐fei¹,Lin Li‐mei¹^ORCID,Zhou Rui¹,Zhang Zong‐kai¹^ORCID,Lin Qin¹^ORCID

Affiliation:

1. Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University Teaching Hospital of Fujian Medical University Xiamen China

2. Department of General Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University Teaching Hospital of Fujian Medical University Xiamen China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4643

Reference24 articles.

1. Uterine sarcomas

2. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics;Bocker W;Verhandlungen der Deutschen Gesellschaft Fur Pathologie,2002

3. Uterine sarcomas

4. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine Sarcoma, Review of Advances in Management in the Last Decade;Indian Journal of Gynecologic Oncology;2024-07-26

2. A nomogram-based overall survival stratification to identify uterine sarcoma patients without distant metastases who may benefit from adjuvant radiotherapy;Gynecologic Oncology;2023-02